Tracheostomy in 80 COVID-19 Patients: A Multicenter, Retrospective, Observational Study.
Front Med (Lausanne)
; 7: 615845, 2020.
Article
in English
| MEDLINE | ID: covidwho-1016068
Semantic information from SemMedBD (by NLM)
1. Tracheostomy procedure TREATS COVID-19
2. COVID-19 PROCESS_OF Patients
3. Tracheostomy procedure TREATS Patients
4. Tracheostomy procedure TREATS Pneumonia
5. 2019 novel coronavirus PROCESS_OF Patients
6. intensive care unit LOCATION_OF Observational Study
7. Tracheotomy procedure ADMINISTERED_TO Physicians
8. Weaning PROCESS_OF Patients
9. Pneumonia PROCESS_OF Patients
10. Tracheostomy procedure TREATS COVID-19
11. COVID-19 PROCESS_OF Patients
12. Tracheostomy procedure TREATS Patients
13. Tracheostomy procedure TREATS Pneumonia
14. 2019 novel coronavirus PROCESS_OF Patients
15. intensive care unit LOCATION_OF Observational Study
16. Tracheotomy procedure ADMINISTERED_TO Physicians
17. Weaning PROCESS_OF Patients
18. Pneumonia PROCESS_OF Patients
ABSTRACT
Background:
The outbreak of coronavirus disease 2019 (COVID-19) has led to a large and increasing number of patients requiring prolonged mechanical ventilation and tracheostomy. The indication and optimal timing of tracheostomy in COVID-19 patients are still unclear, and the outcomes about tracheostomy have not been extensively reported. We aimed to describe the clinical characteristics and outcomes of patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia who underwent elective tracheostomies.Methods:
The multi-center, retrospective, observational study investigated all the COVID-19 patients who underwent elective tracheostomies in intensive care units (ICUs) of 23 hospitals in Hubei province, China, from January 8, 2020 to March 25, 2020. Demographic information, clinical characteristics, treatment, details of the tracheostomy procedure, successful weaning after tracheostomy, and living status were collected and analyzed. Data were compared between early tracheostomy patients (tracheostomy performed within 14 days of intubation) and late tracheostomy patients (tracheostomy performed after 14 days).Results:
A total of 80 patients were included. The median duration from endotracheal intubation to tracheostomy was 17.5 [IQR 11.3-27.0] days. Most tracheotomies were performed by ICU physician [62 (77.5%)], and using percutaneous techniques [63 (78.8%)] at the ICU bedside [76 (95.0%)]. The most common complication was tracheostoma bleeding [14 (17.5%)], and major bleeding occurred in 4 (5.0%) patients. At 60 days after intubation, 31 (38.8%) patients experienced successful weaning from ventilator, 17 (21.2%) patients discharged from ICU, and 43 (53.8%) patients had died. Higher 60 day mortality [22 (73.3%) vs. 21 (42.0%)] were identified in patients who underwent early tracheostomy.Conclusions:
In patients with SARS-CoV-2 pneumonia, tracheostomies were feasible to conduct by ICU physician at bedside with few major complications. Compared with tracheostomies conducted after 14 days of intubation, tracheostomies within 14 days were associated with an increased mortality rate.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
/
Risk factors
Language:
English
Journal:
Front Med (Lausanne)
Year:
2020
Document Type:
Article
Affiliation country:
Fmed.2020.615845